Fala, L. (2015). Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non–Small-Cell Lung Cancer. Am Health Drug Benefits.
Style de citation ChicagoFala, Loretta. "Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non–Small-Cell Lung Cancer." Am Health Drug Benefits 2015.
Style de citation MLAFala, Loretta. "Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non–Small-Cell Lung Cancer." Am Health Drug Benefits 2015.
Attention : ces citations peuvent ne pas être correctes à 100%.